|
1
|
Wang Y, Zhou Z, Luo H, et al: Combination
of tamoxifen and antisense human telomerase RNA inhibits glioma
cell proliferation and anti-apoptosis via suppression of telomerase
activity. Mol Med Rep. 3:935–940. 2010.PubMed/NCBI
|
|
2
|
Krakstad C and Chekenya M: Survival
signalling and apoptosis resistance in glioblastomas: opportunities
for targeted therapeutics. Mol Cancer. 9:1352010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lefranc F, Facchini V and Kiss R:
Proautophagic drugs: a novel means to combat apoptosis-resistant
cancers, with a special emphasis on glioblastomas. Oncologist.
12:1395–1403. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu YH, Li ML, Hsu MY, et al: Effects of a
Chinese Herbal Medicine, Guan-Jen-Huang (Aeginetia indica
Linn.), on renal cancer cell growth and metastasis. Evid Based
Complement Alternat Med. 2012:9358602012.PubMed/NCBI
|
|
5
|
Bamba Y, Yun YS, Kunugi A and Inoue H:
Compounds isolated from Curcuma aromatica Salisb. inhibit
human P450 enzymes. J Nat Med. 65:583–587. 2011.
|
|
6
|
Claeson P, Panthong A, Tuchinda P, et al:
Three non-phenolic diarylheptanoids with anti-inflammatory activity
from Curcuma xanthorrhiza. Planta Med. 59:451–454. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsuda H, Ninomiya K, Morikawa T and
Yoshikawa M: Inhibitory effect and action mechanism of
sesquiterpenes from Zedoariae Rhizoma on
D-galactosamine/lipopolysaccharide-induced liver injury. Bioorg Med
Chem Lett. 8:339–344. 1998. View Article : Google Scholar
|
|
8
|
Morikawa T, Matsuda H, Ninomiya K and
Yoshikawa M: Medicinal foodstuffs. XXIX Potent protective effects
of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver
injury induced by D-galactosamine/lipopolysaccharide or tumor
necrosis factor-alpha. Biol Pharm Bull. 25:627–631. 2002.
View Article : Google Scholar
|
|
9
|
Liu Y, Wang W, Fang B, et al: Anti-tumor
effect of germacrone on human hepatoma cell lines through inducing
G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol.
698:95–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong Z, Chen X, Tan W, et al: Germacrone
inhibits the proliferation of breast cancer cell lines by inducing
cell cycle arrest and promoting apoptosis. Eur J Pharmacol.
667:50–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pang M, Wang ZL, Gao CL, Qu P and Li HD:
Characterization of apoptotic changes induced by yessotoxin in the
Bel7402 human hepatoma cell line. Mol Med Rep. 4:547–552.
2011.PubMed/NCBI
|
|
12
|
Gutierrez GJ, Tsuji T, Cross JV, et al:
JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry
and G(2)/M DNA damage checkpoint. J Biol Chem. 285:14217–14228.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weinert T and Hopper AK: tRNA traffic
meets a cell-cycle checkpoint. Cell. 131:838–840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tanaka H, Arakawa H, Yamaguchi T, et al: A
ribonucleotide reductase gene involved in a p53-dependent
cell-cycle checkpoint for DNA damage. Nature. 404:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu W, Ge Y, Ojcius DM, et al: p53
signalling controls cell cycle arrest and caspase-independent
apoptosis in macrophages infected with pathogenic Leptospira
species. Cell Microbiol. 15:1642–1659. 2013.
|
|
16
|
Yan X, Feng J, Ye Z, Miao X, Li W and Yang
D: p53 siRNA inhibits apoptosis of U2OS cells treated with azurin.
Mol Med Rep. 4:1089–1094. 2011.PubMed/NCBI
|
|
17
|
Deng Y and Wu X: Peg3/Pw1 promotes
p53-mediated apoptosis by inducing Bax translocation from cytosol
to mitochondria. Proc Natl Acad Sci USA. 97:12050–12055. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gogada R, Prabhu V, Amadori M, Scott R,
Hashmi S and Chandra D: Resveratrol induces p53-independent,
X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein
oligomerization on mitochondria to initiate cytochrome c release
and caspase activation. J Biol Chem. 286:28749–28760. 2011.
View Article : Google Scholar
|
|
19
|
Tsutsui S, Yasuda K, Suzuki K, et al:
Bcl-2 protein expression is associated with p27 and p53 protein
expressions and MIB-1 counts in breast cancer. BMC Cancer.
6:1872006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pirngruber J and Johnsen SA: Induced G1
cell-cycle arrest controls replication-dependent histone mRNA 3′
end processing through p21, NPAT and CDK9. Oncogene. 29:2853–2863.
2010.PubMed/NCBI
|
|
21
|
Satyanarayana A, Hilton MB and Kaldis P:
p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase
DNA damage checkpoint. Mol Biol Cell. 19:65–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li W, Kotoshiba S, Berthet C, Hilton MB
and Kaldis P: Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative
mechanism for regulation of the G1/S transition. Proc Natl Acad Sci
USA. 106:486–491. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen XZ, Cao ZY, Chen TS, et al: Water
extract of Hedyotis Diffusa Willd suppresses proliferation of human
HepG2 cells and potentiates the anticancer efficacy of low-dose
5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncol Rep.
28:742–748. 2012.
|
|
24
|
Fang Y, Cao Z, Hou Q, et al: Cyclin D1
downregulation contributes to anticancer rffect of isorhapontigenin
on human bladder cancer cells. Mol Cancer Ther. 12:1492–1503. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grillo M, Bott MJ, Khandke N, et al:
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7
breast cancer cells: Effect of regulated overexpression of cyclin
D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4
expression. Breast Cancer Res Treat. 95:185–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
